People

Luke Miels

Luke Miels became GSK Chief Executive Officer and a board director on 1 January 2026, succeeding Emma Walmsley. He joined GSK as Chief Commercial Officer in 2017 after executive roles at AstraZeneca and Roche. He studied biology at Flinders University and earned an MBA at Macquarie University.